Intensity-modulated radiation therapy did not increase the risk for feeding tube dependence for patients with oropharyngeal ...

Please provide your email address to receive an email when new articles are posted on . HPV testing rates in oropharyngeal cancer have increased over time but remain suboptimal. Testing uptake varies ...

A novel multifeature human papillomavirus (HPV) whole genome sequencing liquid biopsy assay detected circulating tumor HPV DNA (ctHPV DNA) with 79% sensitivity and 100% specificity up to 7.8 years ...

PASADENA, Calif. & RIYADH, Saudi Arabia--(BUSINESS WIRE)--OmniPathology, a U.S.-based advanced molecular diagnostics laboratory, today announced a new international collaboration with Delta Medical ...

AJCC9V staging system showed superior hazard consistency, outcome prediction, and balance, but not hazard discrimination. HealthDay News — Version 9 of the American Joint Committee on Cancer (AJCC) ...

Imagine being armed with precautionary measures to fight a disease – like being vaccinated before the flu season arrives.

Proton therapy did not outperform IMRT in quality-of-life outcomes for patients with oropharyngeal cancer. Both treatments achieved similarly strong control and survival, according to new trial ...

Doha: Early detection and advanced treatment techniques have significantly improved cancer care and survival rates for women in Qatar, according to ...

Leanne Addis from Swansea endured a painful sore throat for ten weeks beginning in February 2024, relying on lozenges and ...

A new phase III clinical trial finds that intensity-modulated radiation therapy (IMRT) and proton beam therapy resulted in ...